JP6548809B2 - 口腔内貼付剤の製造方法 - Google Patents

口腔内貼付剤の製造方法 Download PDF

Info

Publication number
JP6548809B2
JP6548809B2 JP2018501739A JP2018501739A JP6548809B2 JP 6548809 B2 JP6548809 B2 JP 6548809B2 JP 2018501739 A JP2018501739 A JP 2018501739A JP 2018501739 A JP2018501739 A JP 2018501739A JP 6548809 B2 JP6548809 B2 JP 6548809B2
Authority
JP
Japan
Prior art keywords
layer
tableting pressure
drug
tableting
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018501739A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2017146106A1 (ja
Inventor
利博 中西
利博 中西
靖久 古瀬
靖久 古瀬
隆明 義永
隆明 義永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of JPWO2017146106A1 publication Critical patent/JPWO2017146106A1/ja
Application granted granted Critical
Publication of JP6548809B2 publication Critical patent/JP6548809B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
JP2018501739A 2016-02-25 2017-02-22 口腔内貼付剤の製造方法 Active JP6548809B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016034522 2016-02-25
JP2016034522 2016-02-25
PCT/JP2017/006633 WO2017146106A1 (fr) 2016-02-25 2017-02-22 Procédé de production d'un patch pour la cavité buccale

Publications (2)

Publication Number Publication Date
JPWO2017146106A1 JPWO2017146106A1 (ja) 2018-09-20
JP6548809B2 true JP6548809B2 (ja) 2019-07-24

Family

ID=59686354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018501739A Active JP6548809B2 (ja) 2016-02-25 2017-02-22 口腔内貼付剤の製造方法

Country Status (3)

Country Link
JP (1) JP6548809B2 (fr)
TW (1) TW201804988A (fr)
WO (1) WO2017146106A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004246837B2 (en) * 2003-06-06 2009-07-16 Ethypharm Orally-dispersible multilayer tablet
CN105407926A (zh) * 2013-05-31 2016-03-16 久光制药株式会社 口腔贴剂

Also Published As

Publication number Publication date
WO2017146106A1 (fr) 2017-08-31
TW201804988A (zh) 2018-02-16
JPWO2017146106A1 (ja) 2018-09-20

Similar Documents

Publication Publication Date Title
CA2566931C (fr) Comprimes presentant une variabilite reduite de liberation de medicament
JP2008501025A5 (fr)
MXPA96005646A (en) Preparation of nifedipine of release prolong
JP2008521932A5 (fr)
JP5775970B2 (ja) 口腔貼付剤
JP2002275053A (ja) 医薬錠剤及びその製造のための方法
WO2015154656A1 (fr) Préparation solide à libération contrôlée avec revêtement partiel
MX2008015358A (es) Composiciones farmaceuticas para liberacion sostenida de fenilefrina.
JP6548809B2 (ja) 口腔内貼付剤の製造方法
CN100477999C (zh) 胶体果胶铋分散片
US8808739B2 (en) Orodispersible tablet containing compacted sildenafil base
TWI816080B (zh) 包括阿托伐他汀以及怡妥錠的雙層片劑及其製造方法
WO2020098904A1 (fr) Forme posologique contenant de la metformine et un inhibiteur de la dipeptidyl peptidase iv
SA04250370A (ar) طرق وتكوينات لتثبيط السليكتين
Agiba et al. Pharmacotechnical development and optimization of multilayered tablets: An updated industrial review with emphasis on bilayer tablets
JP6517575B2 (ja) 積層錠剤
JP7385367B2 (ja) 口腔内崩壊錠
TW201201800A (en) A pharmaceutical controlled release composition of losartan
JP2005145821A (ja) 打錠製剤
TWI394594B (zh) 錠劑藥學組成物及其製造方法
JP2018197228A (ja) 固形製剤
CN107308157A (zh) 一种含有氯吡格雷的复方口服固体制剂及其制备方法
EP2531180A2 (fr) Composition complexe orale comprenant la pseudoéphédrine et la lévocétirizine
AU2004324868B2 (en) High-dosage extended-release formulation of gepirone
CN102475690A (zh) 内含盐酸阿夫唑嗪的缓释片剂

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180528

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190424

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190604

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190625

R150 Certificate of patent or registration of utility model

Ref document number: 6548809

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250